Molecular and immune characteristics for lung adenocarcinoma patients with CMTM6 overexpression
2020 · International Immunopharmacology · 55 citations
https://doi.org/10.1016/j.intimp.2020.106478
M
Meng Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
1.6K
Citations
20
h-index
38
i10-index
Meng Li is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Cancer Immunotherapy and Biomarkers & Economic and Financial Impacts of Cancer. The author has an h-index of 20, co-authored 80 publications.
ORCID: 0000-0002-8537-7872Papers by this author
worksRural-Urban Disparities in Colorectal Cancer Screening, Diagnosis, Treatment, and Survivorship Care: A Systematic Review and Meta-Analysis
2024 · The Oncologist · 43 citations
https://doi.org/10.1093/oncolo/oyad347
Acceptability of cervical cancer screening using visual inspection among women attending a childhood immunization clinic in Uganda
2017 · Papillomavirus Research · 24 citations
https://doi.org/10.1016/j.pvr.2017.06.004
Estimating the Cost of Illness of Giant Cell Arteritis in the United States
2017 · Rheumatology and Therapy · 19 citations
https://doi.org/10.1007/s40744-017-0052-8
[89Zr]-Pertuzumab PET Imaging Reveals Paclitaxel Treatment Efficacy Is Positively Correlated with HER2 Expression in Human Breast Cancer Xenograft Mouse Models
2021 · Molecules · 18 citations
https://doi.org/10.3390/molecules26061568
A Novel Post-Operative ALRI Model Accurately Predicts Clinical Outcomes of Resected Hepatocellular Carcinoma Patients
2021 · Frontiers in Oncology · 9 citations
https://doi.org/10.3389/fonc.2021.665497
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat